Literature DB >> 1422665

Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.

S F Leung1, M W Law, S K Ho.   

Abstract

Low-dose iodine-131 of mean activity 1117 MBq was used to ablate post-operative thyroid remnants in 69 patients with differentiated thyroid cancer. Successful ablation was defined as uptake of less than 1% at 48 h and absence of visible image on the post-ablation scan. Ablation by one dose was successful in 95% of patients after total or subtotal thyroidectomy, and 56% of patients after partial or hemithyroidectomy. All patients with uptake of 10% or less on the pre-ablation scan had successful ablation. The results are compared with other reports using low-dose radioiodine ablation and the significance of the findings discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422665     DOI: 10.1259/0007-1285-65-778-905

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

1.  Remnant uptake as a postoperative oncologic quality indicator.

Authors:  David F Schneider; Kristin A Ojomo; Herbert Chen; Rebecca S Sippel
Journal:  Thyroid       Date:  2013-07-17       Impact factor: 6.568

2.  Outcomes of pure laparoscopic Glissonian pedicle approach hepatectomy for hepatocellular carcinoma: a propensity score matching analysis.

Authors:  Fei Liu; Hongwei Xu; Qin Li; Yonggang Wei; Hongyu Li; Wentao Wang; Tianfu Wen; Hong Wu; Jiayin Yang; Mingqing Xu; Bo Li
Journal:  Surg Endosc       Date:  2018-08-17       Impact factor: 4.584

3.  Empiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number?

Authors:  Ajit S Shinto; K K Kamaleshwaran; Deepu K Shibu; K Vyshak; Joppy Antony
Journal:  World J Nucl Med       Date:  2013-05

Review 4.  Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.

Authors:  Massimiliano Pacilio; Miriam Conte; Viviana Frantellizzi; Maria Silvia De Feo; Antonio Rosario Pisani; Andrea Marongiu; Susanna Nuvoli; Giuseppe Rubini; Angela Spanu; Giuseppe De Vincentis
Journal:  Diagnostics (Basel)       Date:  2022-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.